Certificate PL-26-00034 · GDF-8 1 mg · lot PL-2609-034
VerifyCertificate page
PrymaLab
PrymaLab
PrymaLab Analytical · In-house laboratory
3705 Music Branch Rd, Ashland, KY 41102 · +1 (606) 465-9063 · prymalab.net
Certificate no.
PL-26-00034
Verification key
U9FXNFGF
Scan or enter both at
prymalab.net/testing/verify

Certificate of Analysis · Lot release

GDF-8 1 mg

Lot PL-2609-034 · Lyophilized powder · Label claim 1 mg/vial
Tested in-house by PrymaLab
In-house analytical result,
not an independent third-party test
Lot / batch number
PL-2609-034
Date made
2026-09-16
Date of analysis
2026-09-18
Date issued
2026-10-03
Retest / expiry
2028-09-16
Units in lot / sampled
250 / 2
Storage
−20 °C, desiccated, dark; avoid freeze–thaw
Certificate type
Lot COA, 2 pages
Compound
GDF-8 (Myostatin)
Recombinant human myostatin, mature homodimer
CAS number
Not assigned
Molecular formula
C1100H1646N294O316S24 (homodimer; reduced-chain calculation)
Theoretical mass (avg.)
24,814.0 Da (reduced-chain calculation; 24,796.3 Da with the nine disulfides formed)
Structure
Two identical 109-residue chains (UniProt O14793 residues 267–375): DFGLDCDEHSTESRCCRYPLTVDFEAFGWDWIIAPKRYKANYCSGECEFVFLQKYPHTHLVHQANPRGSAGPCCTPTKMSPINMLYFNGKEQIIYGKIPAMVVDRCGCS; disulfide-linked homodimer (TGF-β cystine knot).
Purity · RP-HPLC, area %
99.10%
Specification 99.0% • main peak at 7.06 min
Identity · Observed Mass
24,814.2 Da
Theoretical 24,814.0 Da • +0.2 Da (8 ppm)
Overall conclusion
PASS
Meets every specification for the tests performed
TestMethodSpecificationResultConclusion
AppearanceVisual inspectionWhite to off-white lyophilized powderWhite lyophilized powderPASS
Identity (mass)LC-MS, ESI positiveTheoretical ± 1.0 Da24,814.2 DaPASS
PurityRP-HPLC, UV 214 nm, area%99.0%99.10%PASS
Largest impurityRP-HPLC, area%1.0%0.37% at 6.24 minPASS
Water contentKarl Fischer5.0%1.8%PASS
Bacterial endotoxinLAL, kinetic≤ 5.0 EU/mg0.21 EU/mgPASS
Sterility / bioburdenUSP <71>, membrane filtrationNo growth after 14 daysNo growth; conformsPASS

1HPLC chromatogram

Data file: GDF8_PL-2609-034_20260918_01 · Column C18, 150 × 4.6 mm · UV 214 nm
0 150 300 mAU 024 6810 Time (min) GDF-8 (Myostatin) — 99.10% @ 7.06 min 0.25% @ 5.62 0.37% @ 6.24 0.28% @ 7.68
Baseline uncropped; main peak and impurities labeled with retention times. Peak table on page 2.
PrymaLab
PrymaLab
Certificate of Analysis · continued
GDF-8 1 mg · Lot PL-2609-034 · Certificate PL-26-00034
Lot PL-2609-034
Method, peak table and approval

2HPLC method · GDF8_PL-2609-034_20260918_01

Instrument
Waters Alliance e2695, SN E2695B742
Data System
Empower 3, Build 3471
Detector
Waters 2998 PDA
Detection Wavelength
214 nm
Column
C18, 150 × 4.6 mm, 3.5 µm
Column Part / Serial
186003326 / USHX18211
Mobile Phase A
0.1% TFA in water
Mobile Phase B
0.1% TFA in MeCN
Flow Rate
1.0 mL/min
Column Temperature
30 °C
Injection Volume
20 µL
Run Time
10 min
Sample Diluent
Water, 0.1% TFA
Sample Concentration
0.5 mg/mL
Blank Injected
Yes
Reference Standard
In-house GDF-8 reference, lot PL-RS-GD8-01, RT 7.04 min

3Gradient program

Time (min)% A% B
0.0955
3.0955
7.05545
8.02080
9.02080
10.0955

4Peak table

PeakRT (min)AreaArea %
15.6210,7500.25
26.2415,9100.37
37.064,261,30099.10
47.6812,0400.28
Total4,300,000100.00
Threshold 0.05% area · Blank subtracted: Y · Purity = main peak area ÷ total integrated area × 100, to two decimals; main peak shaded.

5Identity by mass spectrometry

Instrument
Waters Acquity SQD
Ionization / Mode
ESI, positive
Observed m/z (charge)
1241.7 (20+ [M+20H]) · 1128.9 (22+ [M+22H])
Deconvoluted Mass
24,814.2 Da
Theoretical Mass
24,814.0 Da
Difference
+0.2 Da (8 ppm)
Data File
GDF8_PL-2609-034_MS_20260918_01
Acceptance
Within ± 1.0 Da

6Additional tests

TestPerformed byDateReport / file
Water contentPrymaLab2026-09-19RPT-KF-PL-2609-034
EndotoxinPrymaLab2026-09-20RPT-ET-PL-2609-034
SterilityPrymaLab2026-10-02RPT-ST-PL-2609-034
A test with no row here was not performed on this lot. Outside-laboratory reports, when used, are attached and named below.

7Review and approval

D. Reynolds
Analyst · performed the testing
Date: 2026-09-18
S. Calloway
Reviewer · checked against raw data
Date: 2026-10-02
M. Phelps
Lab Director · approved for release
Date: 2026-10-03